“Initially, ovarian cancer, melanoma, and some sarcomas are the three main targets,” says Dr. Koya, “but the clinical trial is open for patients with other cancers who meet the eligibility requirements."
Immunotherapy
Collected last week from a patient with late-stage ovarian cancer, these are not ordinary T cells; they have been altered and multiplied in the hope that when they are given back to her, they will launch a devastating attack on her cancer cells.
We’re very excited about bringing this new series of clinical trials to our patients. The promise of outsmarting cancer and disarming its defenses by ramping up our own innate immune systems has never been more real.
I have been battling cancer successfully for 11 years. Looking back at my first diagnosis — stage 2 breast cancer, at age 42 — I downplay it now, because what happened next was so tragic.
OK, time to stifle the Thanksgiving jokes about turkey making you drowsy. Yes, there’s an amino acid called tryptophan in turkey, and it does help your body produce a chemical called serotonin, which promotes a good night’s sleep. But chicken, beef, nuts, and cheese also contain tryptophan, and no one’s pointing the finger at them. So if you nod off after dinner, it’s probably due to all the carbs in that pile of brown-and-serve rolls you scarfed down.
Roswell Park is opening a clinical trial to study the CIMAvax-EGF® vaccine, a cancer treatment that was developed in Cuba. It will be used to treat lung cancer, the most common cause of cancer death worldwide. This vaccine trial is innovative in three significant ways.
Amid a historic normalizing of relations between the United States and Cuba, a potentially game-changing step was recently taken in the field of lung cancer research.